Dopamine antagonist and agonist treatment of tardive dyskinesia.
D014150:Antipsychotic Agents / Q000009:adverse effects; D001545:Benserazide / Q000627:therapeutic use; D001562:Benzimidazoles / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D013469:Sulpiride / Q000627:therapeutic use
D014150:Antipsychotic Agents; D001562:Benzimidazoles; D018492:Dopamine Antagonists; D007980:Levodopa; D001545:Benserazide; D013469:Sulpiride; D004298:Dopamine; C015411:oxiperomide